Valrubicin

What is Valrubicin?

Valrubicin (N-trifluoroacetyladriamycin-14-valerate, trade name Valstar) is a chemotherapy drug used to treat bladder cancer. Valrubicin is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder.

It was originally launched as Valstar in the U.S. in 1999 for intravesical therapy of Bacille Calmette-Guérin (BCG)-refractory carcinoma in situ of the urinary bladder in patients in whom cystectomy would be associated with unacceptable morbidity or mortality; however, it was voluntarily withdrawn in 2002 due to manufacturing issues. Valstar was relaunched on September 3, 2009.

Questions and answers on "Valrubicin"

I have tcc of the bladder Removal of 1 rib/kidney/urter/parital bladder/ treated with bcg/tice/interferon x6 thenx3 three resections of reoccurent...

doctor1 MD

Since you are not a candidate for bladder removal, Valstar (Valrubicin) is a good option for intra-vesical therapy since you have already received...

Read Full Thread   Ask a Doctor Now

Recent questions on  Valrubicin

doctor1 MD

I have tcc of the bladder Removal of 1 rib/kidney/urter/parital bladder/ treated with bcg/tice/interferon x6 thenx3 three resections of reoccurent...

Ask Question
Doctor Image
MD

Hi, I am Dr. Andrew Rynne (Family Physician). I will be guiding you through the process. Please write your question below.